Pfizer Inc. (PFE) Earnings History
Earnings Pressure37 years of earnings data (1989–2025) · 5-year EPS trend is negative
Loading earnings history...
Pfizer Inc. (PFE) Earnings Overview
As of July 8, 2026, Pfizer Inc. (PFE) reported trailing twelve-month net income of $7.49B, reflecting -3.5% year-over-year growth. The company earned $1.31 per diluted share over the past four quarters, with a net profit margin of 12.4%.
Looking at the long-term picture, PFE's 5-year EPS compound annual growth rate (CAGR) stands at -3.5%, signaling declining earnings. The company achieved its highest annual net income of $31.36B in fiscal 2022.
Pfizer Inc. maintains positive profitability with a gross margin of 70.3%, operating margin of 24.7%, and net margin of 12.4%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including JNJ ($21.04B net income, 28.5% margin), MRK ($8.94B net income, 28.1% margin), ABBV ($3.64B net income, 6.9% margin), PFE has room to improve margins relative to the peer group. Compare PFE vs JNJ →
PFE Earnings vs Peers
Earnings metrics vs comparable public companies
PFE Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $7.77B | -3.1% | $15.44B | $1.36 | 12.4% | 24.7% |
| 2024 | $8.02B | +276.0% | $16.48B | $1.41 | 12.6% | 25.9% |
| 2023 | $2.13B | -93.2% | $5.29B | $0.37 | 3.6% | 8.9% |
| 2022 | $31.36B | +41.6% | $37.55B | $5.47 | 31.3% | 37.4% |
| 2021 | $22.15B | +141.8% | $20.79B | $3.88 | 27.2% | 25.6% |
| 2020 | $9.16B | -43.7% | $9.09B | $1.63 | 22.0% | 21.8% |
| 2019 | $16.27B | +45.9% | $7.51B | $2.87 | 39.5% | 18.2% |
| 2018 | $11.15B | -47.7% | $15.29B | $1.87 | 20.8% | 28.5% |
| 2017 | $21.30B | +195.3% | $14.39B | $3.52 | 40.5% | 27.4% |
| 2016 | $7.21B | +3.6% | $14.27B | $1.17 | 13.7% | 27.0% |
| 2015 | $6.97B | -23.3% | $13.30B | $1.11 | 14.3% | 27.2% |
| 2014 | $9.08B | -22.1% | $14.03B | $1.41 | 18.3% | 28.3% |
| 2013 | $11.65B | +19.0% | $16.89B | $1.69 | 22.6% | 32.7% |
| 2012 | $9.79B | +12.4% | $18.04B | $1.30 | 17.9% | 33.0% |
| 2011 | $8.71B | +5.3% | $18.38B | $1.11 | 14.3% | 30.1% |
| 2010 | $8.27B | -4.3% | $17.73B | $1.02 | 12.3% | 26.4% |
| 2009 | $8.63B | +7.6% | $16.01B | $1.23 | 17.3% | 32.0% |
| 2008 | $8.02B | -2.3% | $16.63B | $1.19 | 16.6% | 34.4% |
| 2007 | $8.21B | -25.5% | $13.92B | $1.18 | 17.0% | 28.7% |
| 2006 | $11.02B | +44.9% | $15.09B | $1.52 | 22.8% | 31.2% |
| 2005 | $7.61B | -32.8% | $14.53B | $1.02 | 16.1% | 30.7% |
| 2004 | $11.33B | +189.8% | $17.09B | $1.49 | 21.6% | 32.5% |
| 2003 | $3.91B | -57.2% | $10.80B | $0.54 | 8.7% | 23.9% |
| 2002 | $9.13B | +17.2% | $12.28B | $1.46 | 28.2% | 37.9% |
| 2001 | $7.79B | +109.0% | $10.98B | $1.22 | 24.1% | 34.0% |
| 2000 | $3.73B | +17.2% | $8.67B | $0.59 | 12.6% | 29.3% |
| 1999 | $3.18B | -5.1% | $4.55B | $0.78 | 19.6% | 28.1% |
| 1998 | $3.35B | +51.4% | $3.60B | $0.85 | 24.7% | 26.6% |
| 1997 | $2.21B | +14.7% | $3.35B | $0.56 | 17.7% | 26.8% |
| 1996 | $1.93B | +22.6% | $3.08B | $0.50 | 17.1% | 27.2% |
| 1995 | $1.57B | +21.1% | $2.56B | $0.42 | 15.7% | 25.5% |
| 1994 | $1.30B | +97.5% | $1.97B | $0.35 | 15.7% | 23.8% |
| 1993 | $658M | -18.9% | $913M | $0.17 | 8.8% | 12.2% |
| 1992 | $811M | +12.3% | $1.44B | $0.20 | 11.2% | 20.0% |
| 1991 | $722M | -9.9% | $1.25B | $0.18 | 10.4% | 18.0% |
| 1990 | $801M | +17.6% | $1.05B | $0.21 | 12.5% | 16.5% |
| 1989 | $681M | - | $968M | $0.16 | 12.0% | 17.1% |
Download Data
Export PFE earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PFE — Frequently Asked Questions
Quick answers to the most common questions about buying PFE stock.
What is PFE earnings per share (EPS)?
PFE trailing twelve-month (TTM) diluted EPS is $1.31, reflecting -3.5% year-over-year growth. The 5-year EPS CAGR is -3.5%. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is Pfizer Inc.'s net income?
Pfizer Inc. (PFE) trailing twelve-month net income is $7.5B as of 2025. Earnings declined -3.5% year-over-year. Pfizer Inc. has been profitable for 37 consecutive years.
Is PFE profitable?
Yes, PFE is profitable with a TTM net income of $7.5B and a net profit margin of +12.4%. Pfizer Inc. has generated profits for 37 consecutive years.
What is PFE's earnings growth rate?
PFE compound annual EPS growth rates (CAGR): 1-Year: -3.5%, 3-Year: -37.1%, 5-Year: -3.5%, 10-Year: +2.0%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are PFE's profit margins?
Pfizer Inc. net profit margin is +12.4%, operating margin is +24.7%, and gross margin is +70.3%. Margins are within a typical range for the sector. Return on Equity is +8.9%.
Is PFE growing earnings?
PFE earnings growth is slowing. Current YoY EPS growth of -3.5% trails the 5-year CAGR of -3.5%. TTM net income is $7.5B.
What was PFE's best earnings year?
Pfizer Inc.'s highest annual net income on record is $31.4B, achieved in fiscal year 2022. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were PFE's earnings last quarter?
PFE's most recent reported quarter was Q1 2026. Net income was $2.7B with diluted EPS of $0.47. For a full breakdown of all quarters, see the quarterly earnings table on this page.